Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment
血浆蛋白质组学生物标志物可预测接受卡瑞利珠单抗联合吉西他滨(GEMOX)治疗的晚期胆道癌患者的治疗反应。
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-00879-9
Cui, Shiyun; Zheng, Hejian; Xu, Yiyang; Wu, Qiuyu; Liu, Weici; Cai, Yucheng; Fan, Lei; Tian, Yitong; Qian, Hao; Ding, Yuting; Zhang, Xinyi; Zhang, Jiaguang; Wu, Xiaofeng; Wang, Rong; Li, Xiangcheng; Chen, Xiaofeng